Thomsen And Becker Disease
Description
Myotonia congenita is characterised by slow muscle relaxation associated with hyperexcitation of the muscle fibres.
Clinical Features
Phenotypes and symptoms related to Thomsen And Becker Disease
- EMG abnormality
- Myotonia
Incidence and onset information
— Based on the latest data available THOMSEN AND BECKER DISEASE have a estimated prevalence of 1 per 100k in Europe.— No data available about the known clinical features onset.
Alternative names
Thomsen And Becker Disease Is also known as myotonia congenita.
Researches and researchers
Doctors, researchs, and experts related to Thomsen And Becker Disease extracted from public data.
Thomsen And Becker Disease Experts map
Current Researchs and researchers
-
Investigator of research projectLEIDEN — Dr J.A.H. [Just] EEKHOF
-
Institution/s:
— LUMC - Leids Universitair Medisch Centrum -
Research area/topic::
GMA - Group medical appointments for neuromuscular patients: To compare group medical appointments (shared medical appointments or group visits) with conventional one to one appointments for patients with a chronic neuromuscular disease in terms of health outcome (quality of life) and costs, an intervention study.
-
Institution/s:
-
Investigator of research projectUTRECHT — Ms F. [Femke] SEESING
-
Institution/s:
— Piet van Dommelenhuis -
Research area/topic::
GMA - Group medical appointments for neuromuscular patients: To compare group medical appointments (shared medical appointments or group visits) with conventional one to one appointments for patients with a chronic neuromuscular disease in terms of health outcome (quality of life) and costs, an intervention study.
-
Institution/s:
Thomsen And Becker Disease Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Athena Diagnostics Inc (United States).
CLCN1
Specificity
100 %
Genes
100 % |
![]() By Athena Diagnostics Inc (United States).
SCN4A, CLCN1, DMPK
Specificity
34 %
Genes
100 % |
![]() By Athena Diagnostics Inc (United States).
SCN4A, CNBP, CAV3, CLCN1, DMPK, HSPG2, ATP2A1
Specificity
15 %
Genes
100 % |
![]() By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, BIN1, SCN4A, SGCA, SGCB, SGCD, SGCE, SGCG, SLC25A4, SUCLA2, SUCLG1, TWNK, TCAP, TIA1, TK2, TNNI2, TNNT1, TPM2, TPM3, MYOT , (...)
View the complete list with 124 more genes
Specificity
1 %
Genes
100 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
CLCN1
Specificity
100 %
Genes
100 % |
![]() By CGC Genetics (Portugal).
CLCN1
Specificity
100 %
Genes
100 % |
![]() By CGC Genetics (Portugal).
SCN4A, CACNA1A, CACNA1S, CAV3, CLCN1, KCNJ18, HINT1, HSPG2, KCNA1, KCNE3, ATP2A1
Specificity
10 %
Genes
100 % |
![]() By CGC Genetics (Portugal).
CLCN1
Specificity
100 %
Genes
100 % |
You can get up to 40 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MUCOLIPIDOSIS III GAMMA